A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Clinical trial NCT05600777 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05600777
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2026-06-10
- Enrollment
- 997
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.